直接抗病毒药物时代下对丙型肝炎研究的挑战
Hepatitis C virus (HCV) is an important human pathogen that causes chronic viral hepatitis worldwide. HCV infection, often persistent and asymptomatic, could lead to liver fibrosis/cirrhosis and hepatocellular carcinoma. The interferon/ribavirin therapy has been widely used for treating chronic hepa...
Main Author: | ZHONG Jin |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2014-06-01
|
Series: | Linchuang Gandanbing Zazhi |
Subjects: | |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=5805&ClassID=4241494 |
Similar Items
-
难治性丙型肝炎再认识—谈丙型肝炎抗病毒治疗策略的进展
by: DOU Xiaoguang
Published: (2014-06-01) -
难治性慢性丙型肝炎患者抗病毒治疗中NK细胞和Treg细胞的动态变化
by: CHEN Xiaoyun
Published: (2014-06-01) -
血脂水平与慢性丙型肝炎患者抗病毒疗效的相关性分析
by: SHI Jia
Published: (2014-06-01) -
乙型肝炎病毒相关肝硬化的临床诊断、评估和抗病毒治疗的综合管理
by: Experts in combined team of the Major Special Project of Ministry of Science and Technology supported by China’s “Twelfth Five-Year Plan”
Published: (2014-02-01) -
急性丙型肝炎的诊断及治疗
by: ZHAO Ning
Published: (2014-06-01)